Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
20/04/2026 13:01
Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS TO DISCUSS FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 12, 2026 CONFERENCE CALL AND PROVIDE BUSINESS UPDATE Source text: ID:nPn20S5H6a Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program